The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 1,134 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 13,870 | 237,500 | SH | SOLE | 237,500 | 0 | 0 | ||
| ALLSCRIPTS HEALTHCARE SOLUTN | COM | 01988P108 | 3,931 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 2,819 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| AMYRIS INC | COM | 03236M101 | 3,180 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 4,430 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 2,318 | 25,500 | SH | SOLE | 25,500 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 11,777 | 294,500 | SH | SOLE | 294,500 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 1,464 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 3,240 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
| CURIS INC | COM | 231269101 | 639 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 3,065 | 177,500 | SH | SOLE | 177,500 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 2,976 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 8,318 | 485,000 | SH | SOLE | 485,000 | 0 | 0 | ||
| EVOLENT HEALTH INC | CL A | 30050B101 | 11,596 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 15,480 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 5,128 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 3,740 | 101,500 | SH | SOLE | 101,500 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 2,859 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 3,336 | 42,500 | SH | SOLE | 42,500 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 15,149 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 3,485 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 3,619 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 18,123 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 4,420 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 7,201 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 2,902 | 182,141 | SH | SOLE | 182,141 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 2,693 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 6,620 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||